Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Developing differentiated therapies for patients in need that target nodes of cancer growth, spread9.16M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States9.16M100.00%